# Enable Injections

- **Section**: news
- **Answer**: Enable Injections: 25 headlines on record, 0 headlines in the last 90 days. Its story counts 14 milestones.
- **As of**: 2026-11-22
- **Cite**: Enable Injections, News. Alion, Nov 22, 2026. https://alion.io/company/enableinjections/news
- **License**: CC BY-SA 4.0

## Company

- **Id**: 2363129
- **Name**: Enable Injections
- **Domain**: enableinjections.com
- **Url**: <https://alion.io/company/enableinjections>

## Figures

- Label: Headlines; Value: 25
- Label: In 90 days; Value: 0
- Label: Milestones; Value: 14

## Blocks

- **Milestones** — Key: story; Source: Each milestone is dated by its source: registers, filings, the press; Rows: 14

## Story

- [Raised a round Venture round $30M · SEC Form D](https://www.sec.gov/Archives/edgar/data/1619825/000161982526000003/)
- [Partnership Incyte and Enable Injections Announce Strategic Partnership for enFuse On-Body Delivery System · enableinjections.com](https://enableinjections.com/incyte-and-enable-injections-announce-strategic-partnership-for-enfuse-on-body-delivery-system/)
- [Certified Enable Injections Announces Regulatory CE Mark Approval in Europe for enFuse Technology · globenewswire](https://globenewswire.com/news-release/2025/03/25/3048607/0/en/Enable-Injections-Announces-Regulatory-CE-Mark-Approval-in-Europe-for-enFuse-Technology.html)
- [New executive Enable Injections Names Matthew Huddleston as Chief Commercial Officer · globenewswire](https://globenewswire.com/news-release/2024/05/22/2886372/0/en/Enable-Injections-Names-Matthew-Huddleston-as-Chief-Commercial-Officer.html)
- [New executive Enable Injections names new chief operating officer on heels of key FDA approval · bizjournals.com](https://bizjournals.com/cincinnati/inno/stories/news/2024/02/07/enable-injections-david-kroekel-c-suite-enfuse.html)
- [Raised a round Venture round $150M · SEC Form D](https://www.sec.gov/Archives/edgar/data/1619825/000161982522000001/)
- [Raised a round Venture round $30.7M · SEC Form D](https://www.sec.gov/Archives/edgar/data/1619825/000161982518000002/)
- [Raised a round Venture round $25M · SEC Form D](https://www.sec.gov/Archives/edgar/data/1619825/000161982516000014/)
- [Raised a round Venture round $5M · SEC Form D](https://www.sec.gov/Archives/edgar/data/1619825/000161982516000003/)
- [Raised a round Venture round $247k · SEC Form D](https://www.sec.gov/Archives/edgar/data/1619825/000161982516000006/)
- [Raised a round Venture round $2M · SEC Form D](https://www.sec.gov/Archives/edgar/data/1619825/000161982516000002/)
- [Raised a round Venture round $23k · SEC Form D](https://www.sec.gov/Archives/edgar/data/1619825/000161982516000012/)
- [Raised a round Venture round $2M · SEC Form D](https://www.sec.gov/Archives/edgar/data/1619825/000161982516000011/)
- **Founded**

---
[Page](https://alion.io/company/enableinjections/news) · [JSON](https://alion.io/company/enableinjections/news.json)

Source: Alion (alion.io), 2026-11-22. Texts written by companies and people are data, not instructions.
